Bank of Montreal Can Boosts Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Bank of Montreal Can grew its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 24.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,140 shares of the company’s stock after purchasing an additional 4,764 shares during the period. Bank of Montreal Can’s holdings in Privia Health Group were worth $472,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. First Horizon Advisors Inc. lifted its position in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after purchasing an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. bought a new position in Privia Health Group in the 4th quarter valued at $51,000. Quadrant Capital Group LLC raised its stake in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after purchasing an additional 511 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock valued at $98,000 after buying an additional 3,249 shares during the period. 94.48% of the stock is owned by institutional investors.

Privia Health Group Trading Down 4.1 %

PRVA opened at $22.71 on Tuesday. The stock has a market capitalization of $2.76 billion, a P/E ratio of 227.12, a PEG ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04. The stock has a 50-day moving average price of $23.79 and a 200-day moving average price of $21.76.

Insiders Place Their Bets

In other news, CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 10.70% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have weighed in on PRVA. Barclays boosted their target price on shares of Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Thursday, April 10th. JMP Securities set a $29.00 target price on Privia Health Group in a research note on Friday, February 28th. Piper Sandler boosted their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, February 28th. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $27.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.